← Eichor
Condition: Leptomeningeal Metastasis Of Her2 Positive Breast Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Leptomeningeal Metastasis Of Her2 Positive Breast Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease
Phase 2 · 11 location(s) · UNICANCER · NCT05800275Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Trastuzumab in Breast Cancer With Lept
Phase 2 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT07263425
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.